Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 31.34B | 32.01B | 28.59B | 25.89B | 23.30B | 21.02B |
Gross Profit | 11.02B | 11.29B | 10.25B | 9.47B | 8.82B | 8.26B |
EBITDA | 7.26B | 9.48B | 8.38B | 7.81B | 7.73B | 7.42B |
Net Income | 1.76B | 1.79B | 1.58B | 1.51B | 1.68B | 1.73B |
Balance Sheet | ||||||
Total Assets | 26.96B | 26.71B | 25.40B | 23.17B | 21.32B | 20.22B |
Cash, Cash Equivalents and Short-Term Investments | 826.00M | 740.61M | 711.88M | 1.49B | 1.75B | 1.68B |
Total Debt | 3.16B | 2.26B | 1.36B | 610.00M | 59.72M | 20.00M |
Total Liabilities | 10.24B | 9.19B | 8.85B | 7.08B | 5.81B | 5.62B |
Stockholders Equity | 16.70B | 17.51B | 16.54B | 16.07B | 15.50B | 14.60B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 538.71M | -438.56M | -905.70M | -754.64M | 1.34B |
Operating Cash Flow | 0.00 | 1.39B | 339.18M | -7.10M | 53.25M | 1.80B |
Investing Cash Flow | 0.00 | -1.17B | -775.78M | 132.78M | 741.98M | -1.04B |
Financing Cash Flow | 0.00 | -189.88M | -343.30M | -381.96M | -724.64M | -694.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥28.95B | 8.06 | 4.00% | 17.40% | 17.97% | ||
77 Outperform | ¥36.43B | 15.71 | 2.85% | 6.59% | 19.67% | ||
71 Outperform | ¥12.08B | 8.13 | 3.66% | 2.12% | -6.76% | ||
71 Outperform | ¥10.85B | 8.48 | 3.99% | 6.95% | 4.92% | ||
70 Outperform | ¥39.57B | 7.63 | 2.00% | 14.18% | 45.35% | ||
66 Neutral | £2.71B | 11.98 | 4.22% | 3.38% | 2.19% | -20.98% | |
63 Neutral | ¥32.29B | 17.03 | 3.35% | 11.34% | 15.91% |